Viking Therapeutics Aktie
WKN DE: A12GD6 / ISIN: US92686J1060
19.08.2025 00:18:07
|
Why Viking Therapeutics Stock Zoomed 5% Higher Today
Good news from a peer and a positive analyst update were the elements driving Viking Therapeutics (NASDAQ: VKTX) stock higher on the first trading day of the week.The clinical-stage biotech, closely watched by some because of its investigational weight-loss drug VK2735, saw its share price improve by more than 5% as a result. By contrast, the S&P 500 index basically traded flat across the trading session. The news driving Viking and other obesity drug developers came from a leading company in that space, Wegovy maker Novo Nordisk.Continue readingWeiter zum vollständigen Artikel bei MotleyFool

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Viking Therapeutics Incmehr Nachrichten
22.07.25 |
Ausblick: Viking Therapeutics öffnet die Bücher zum abgelaufenen Quartal (finanzen.net) |
Analysen zu Viking Therapeutics Incmehr Analysen
Aktien in diesem Artikel
Viking Holdings Ltd Registered Shs | 62,24 | -0,70% |
|
Viking Therapeutics Inc | 21,95 | 10,57% |
|